Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6E3I

Human Bfl-1 in complex with the Bfl-1-specific designed peptide srt.F4

Summary for 6E3I
Entry DOI10.2210/pdb6e3i/pdb
DescriptorBcl-2-related protein A1, peptide srt.F4, SULFATE ION, ... (4 entities in total)
Functional Keywordsanti-apoptotic bcl-2, inhibitor, design, apoptosis
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight19877.60
Authors
Jenson, J.M.,Keating, A.E. (deposition date: 2018-07-14, release date: 2018-10-17, Last modification date: 2020-01-01)
Primary citationJenson, J.M.,Xue, V.,Stretz, L.,Mandal, T.,Reich, L.L.,Keating, A.E.
Peptide design by optimization on a data-parameterized protein interaction landscape.
Proc. Natl. Acad. Sci. U.S.A., 115:E10342-E10351, 2018
Cited by
PubMed Abstract: Many applications in protein engineering require optimizing multiple protein properties simultaneously, such as binding one target but not others or binding a target while maintaining stability. Such multistate design problems require navigating a high-dimensional space to find proteins with desired characteristics. A model that relates protein sequence to functional attributes can guide design to solutions that would be hard to discover via screening. In this work, we measured thousands of protein-peptide binding affinities with the high-throughput interaction assay amped SORTCERY and used the data to parameterize a model of the alpha-helical peptide-binding landscape for three members of the Bcl-2 family of proteins: Bcl-x, Mcl-1, and Bfl-1. We applied optimization protocols to explore extremes in this landscape to discover peptides with desired interaction profiles. Computational design generated 36 peptides, all of which bound with high affinity and specificity to just one of Bcl-x, Mcl-1, or Bfl-1, as intended. We designed additional peptides that bound selectively to two out of three of these proteins. The designed peptides were dissimilar to known Bcl-2-binding peptides, and high-resolution crystal structures confirmed that they engaged their targets as expected. Excellent results on this challenging problem demonstrate the power of a landscape modeling approach, and the designed peptides have potential uses as diagnostic tools or cancer therapeutics.
PubMed: 30322927
DOI: 10.1073/pnas.1812939115
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.481 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon